The company have substantially improved the course of a novel treatment for amyloid heart disease, employing the investigational drug. Preliminary patient results suggests significant improvements for those affected https://bridgebio880599.angelinsblog.com/40856376/company-improves-cardiac-amyloidosis-therapy-through-the-drug